Medical Oncology 101 for Healthcare Professionals | eviCore Webinar Series

The field of medical oncology continues to advance at an accelerating pace. In 2020, the FDA approved 21 new oncology drugs, 2 biosimilars, and 36 new or expanded drug indications, for a total of 59 oncology drug approvals. Among these are some first-in-class products. The Journal of Clinical Pathways recently released a special report documenting the rapid pace of change in the field of medical oncology: “New Approved Treatments and Indications in Oncology: Highlights from 2020.”

Join us on August 24th when Dr. Stephen Hamilton, eviCore’s Chief of Medical Oncology, and Richard Emery, eviCore's Vice President of Comprehensive Oncology Strategy, will provide an overview of the field for health plan representatives.

Learning Objectives:
Understand the major categories of medical oncology treatment and supportive drugs
Understand how these treatment categories work to fight cancer
Appreciate how the field of medical oncology has changed over the last two decades and what we can expect in the future.